Isabl

Cancer tests based on whole genome and transcriptome data.

Operating in healthcare based in New York, NY, USA; Remote, Isabl operates.

Profile

Isabl has developed software that can analyze the entire genome of cancer patients.

Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations.

Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.

Within the healthcare space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in New York, NY, USA; Remote.

Directory data places it at the Winter 2020 stage.

Its team size is recorded as 5 employees.

Website: isabl.io